Oncogenic role of TWF2 in human tumors: A pan-cancer analysis

Wenjie Liu1,2, Gengwei Huo1,3, Peng Chen4

  • 1Department of Thoracic Oncology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy of Tianjin, Tianjin, China.

Insights

This study reveals the oncogenic role of TWF2 across various cancers using pan-cancer analysis. It highlights TWF2

Area of Science:

  • Oncology
  • Molecular Biology
  • Genomics

Background:

  • Understanding oncogenic mechanisms is crucial for developing effective cancer medicines.
  • TWF1, part of the actin-depolymerizing factor homology family, is implicated in lung, breast, and pancreatic cancers.
  • The role of TWF2, a related protein, in cancer is largely unexplored, with no prior comprehensive pan-cancer studies.

Purpose of the Study:

  • To investigate the role of TWF2 in various human malignancies.
  • To provide a comprehensive pan-cancer overview of TWF2's oncogenic effects.

Main Methods:

  • Utilized The Cancer Genome Atlas (TCGA) and Gene Expression Omnibus (GEO) datasets.
  • Examined TWF2 transcription levels and mutation frequency across different cancer types.
  • Analyzed potential functional pathways associated with TWF2-mediated oncogenicity.

Main Results:

  • TWF2 exhibits altered transcription across a wide spectrum of human cancers.
  • TWF2 mutations were identified in various malignancies, suggesting its involvement in cancer development.
  • Functional pathway analysis indicated potential mechanisms through which TWF2 contributes to oncogenesis.

Conclusions:

  • TWF2 plays a significant, previously underappreciated role in multiple human cancers.
  • This pan-cancer analysis provides a foundational understanding of TWF2's oncogenic potential.
  • Further research into TWF2 could lead to novel therapeutic strategies for a broad range of cancers.

Related Concept Videos

Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.9K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
5.1K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.1K
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
12.5K
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.5K
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.2K